Ria Uhlig

1.5k total citations
6 papers, 79 citations indexed

About

Ria Uhlig is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ria Uhlig has authored 6 papers receiving a total of 79 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ria Uhlig's work include Monoclonal and Polyclonal Antibodies Research (2 papers), Prostate Cancer Treatment and Research (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Ria Uhlig is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (2 papers), Prostate Cancer Treatment and Research (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Ria Uhlig collaborates with scholars based in Germany. Ria Uhlig's co-authors include C. Keller, David Dum, Sören Weidemann, York Hildebrandt, A. R. Zander, Andreas M. Luebke, Katrin Bartels, Sabrina Meyer, Doris Höflmayer and Georgia Makrypidi‐Fraune and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer Research and Annals of Oncology.

In The Last Decade

Ria Uhlig

6 papers receiving 79 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ria Uhlig Germany 3 44 24 23 21 17 6 79
Anna Reischer Germany 5 32 0.7× 24 1.0× 36 1.6× 21 1.0× 12 0.7× 8 85
Timothy F. Goggins United States 7 50 1.1× 10 0.4× 7 0.3× 21 1.0× 21 1.2× 12 89
Marie Luise Hütter‐Krönke Germany 5 57 1.3× 29 1.2× 11 0.5× 43 2.0× 21 1.2× 9 105
Michael Rainone United States 4 66 1.5× 19 0.8× 15 0.7× 6 0.3× 9 0.5× 8 83
Carl Cook United States 8 93 2.1× 59 2.5× 24 1.0× 41 2.0× 9 0.5× 12 137
Hong L. Tiv United States 5 40 0.9× 68 2.8× 22 1.0× 18 0.9× 50 2.9× 7 130
Fabiola Bene United Kingdom 2 25 0.6× 27 1.1× 36 1.6× 4 0.2× 22 1.3× 2 137
Méryem-Maud Farhat France 5 15 0.3× 47 2.0× 10 0.4× 16 0.8× 41 2.4× 15 107
Claudia Tandler Germany 5 28 0.6× 27 1.1× 26 1.1× 7 0.3× 17 1.0× 11 74
Hélène Zattara France 7 15 0.3× 27 1.1× 9 0.4× 22 1.0× 20 1.2× 13 85

Countries citing papers authored by Ria Uhlig

Since Specialization
Citations

This map shows the geographic impact of Ria Uhlig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ria Uhlig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ria Uhlig more than expected).

Fields of papers citing papers by Ria Uhlig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ria Uhlig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ria Uhlig. The network helps show where Ria Uhlig may publish in the future.

Co-authorship network of co-authors of Ria Uhlig

This figure shows the co-authorship network connecting the top 25 collaborators of Ria Uhlig. A scholar is included among the top collaborators of Ria Uhlig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ria Uhlig. Ria Uhlig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Lennartz, Maximilian, Niclas C. Blessin, Simon Kind, et al.. (2023). 2355P Carcinoembryonic antigen (CEA) expression in human tumors: A tissue microarray study on 15,413 tumors. Annals of Oncology. 34. S1197–S1197. 1 indexed citations
2.
Lennartz, Maximilian, Florian Viehweger, David Dum, et al.. (2023). Abstract 5457: Prevalence of “low” HER2 expression is frequent in breast cancer but also in cancers of other origin: A tissue microarray study on 131 tumor types. Cancer Research. 83(7_Supplement). 5457–5457. 1 indexed citations
3.
Uhlig, Ria, Sören Weidemann, Doris Hoeflmayer, et al.. (2021). Carboxypeptidase A1 (CPA1) immunohistochemistry is highly sensitive and specific for acinar cell carcinoma (ACC) of the pancreas. Pathology. 53. S43–S43. 2 indexed citations
4.
Kluth, Martina, Claudia Hube‐Magg, Georgia Makrypidi‐Fraune, et al.. (2020). Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG‐negative prostate cancer. The Prostate. 80(13). 1097–1107. 18 indexed citations
5.
Kluth, Martina, Claudia Hube‐Magg, Georgia Makrypidi‐Fraune, et al.. (2020). High B7‐H3 expression is linked to increased risk of prostate cancer progression. Pathology International. 70(10). 733–742. 19 indexed citations
6.
Hildebrandt, York, Yan Cao, C. Keller, et al.. (2012). Role of Interleukin 16 in Multiple Myeloma. JNCI Journal of the National Cancer Institute. 104(13). 1005–1020. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026